![](/img/cover-not-exists.png)
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
Squires, J, Houston, N, Kohn, E C, Lee, J-M, Sarosy, G A, Annunziata, C M, Azad, N, Minasian, L, Kotz, HVolume:
102
Year:
2010
Language:
english
Pages:
5
DOI:
10.1038/sj.bjc.6605514
File:
PDF, 211 KB
english, 2010